CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Phenotypic and genotypic expression of clindamycin resistance Among clinical isolates of staphylococcus aureus

Author: 
Geeta, S.H. and Rama, N.K.
Subject Area: 
Health Sciences
Abstract: 

Resistance to antimicrobial agents among Staphylococcus aureus is an increasing problem. Emergence of Methicillin resistance in hospital acquired and also among community acquired Staphylococcus aureus has resulted with very few therapeutic options to treat staphylococcal infections. The Macrolide Lincosamide Streptogramin B [MLSB] family of antibiotics is one such alternative with clindamycin being the preferred drug due to its excellent pharmacokinetic properties. Hence clindamycin is commonly used to treat serious infections including skin and soft tissue infections produced by drug resistant Staphylococcus aureus including MRSA. As clindamycin is a safe drug to use in serious MRSA infections, it was continuously misused resulting in increased resistance to the drug. Clindamycin resistance may be constitutive or inducible. Two common genes responsible for resistance to macrolide, lincosamide and streptogramin B (MLSB) antibiotics are the ermA and ermC genes. In vitro routine tests for clindamycin susceptibility may fail to detect inducible clindamycin resistance due to erm genes resulting in treatment failure; thus necessitating the need to detect such resistance by a simple disc approximation test [D test] on a routine basis. The present study was undertaken to know the rate of inducible clindamycin resistance and erm genes among clinical isolates of Staphylococcus aureus in our hospital. Materials and Methods: 355 Staphylococcal species were isolated from various clinical specimen in the department of microbiology over a period of 6 months. Of which, 81 S. aureus isolated and identified by standard protocol were included in the present study. MRSA & MSSA were detected using cefoxitin [30 µg] disc as per CLSI criteria. Antibiotic sensitivity to routine antimicrobial agents was done by Kirby Bauer’s disk diffusion method. D test was performed on all erythromycin resistant MRSA and MSSA isolates to detect phenotypic expression of clindamycin resistance. ermA and ermC genome identified by PCR on D test positive isolates. Results: Out of 81 isolates of S. aureus, 18 (22%) were found to be MRSA & 63(78%) MSSA. Erythromycin resistance was seen in 70(86%) & 11(14%) were erythromycin sensitive of S aureus. Out of the total 70 erythromycin resistant strains of Staph aureus, 22(31%) isolates showed inducible clindamycin resistance, 26(37%) showed constitutive clindamycin resistance and 22(31%) were MS phenotypes. Hence D test was positive among 16(73%) MSSA & 06(27%) MRSA isolates. D test positive strains (22) were tested for ermA and ermC genes. 4/22(18.2%) ermA genes and 15/22(68.2%) ermC in erythromycin resistant S aureus strains respectively. Conclusion: Clindamycin is a very safe and effective drug which can be used against CA & HA MRSA infection. Development of in vivo therapeutic failure can be prevented by doing a D test routinely in microbiology lab.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran